Investigate safety/tolerability after a single dose intranasal administration of AZD8848 comparator placebo to healthy male volunteers and seasonal allergic rhinitis male patients out of season
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Enrollment
130
Research Site
Lund, Sweden
Incidence/nature of adverse events, 12-lead ECG, pulse, BP, body temperature, spirometry
Time frame: During the study
Clinical chemistry, haematology, urinalysis
Time frame: During the study
Nasal symptoms and peak nasal inspiratory flow
Time frame: During the study
Pharmacokinetics
Time frame: During the study
Biomarkers nasal lavage and blood
Time frame: During the study
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.